See the DrugPatentWatch profile for uzedy
How much does UZEDY cost without insurance?
UZEDY (risperidone extended-release injectable suspension), used for schizophrenia in adults, has a wholesale acquisition cost (WAC) of about $3,000 to $4,200 per dose, depending on the strength (50 mg to 250 mg every 1 or 2 months). A 100 mg monthly dose, for example, lists around $3,485 WAC as of mid-2024.[1][2]
What affects the actual price patients pay?
Prices vary by insurance, pharmacy, and discounts. With commercial insurance, copays can drop to $0-$50 after manufacturer coupons from Teva Pharmaceuticals. Medicare patients may face $100-$400 out-of-pocket, depending on Part D plans. Uninsured patients can use the UZEDY savings card for as low as $0 for up to 12 fills (max $1,800 savings per year).[3][4]
How do monthly costs compare for long-acting schizophrenia injectables?
| Medication | Dose Frequency | Approx. WAC per Dose |
|------------|----------------|----------------------|
| UZEDY | 1-2 months | $3,000-$4,200 |
| Invega Sustenna | 1 month | $2,800-$3,200 |
| Invega Trinza | 3 months | $5,500-$6,500 |
| Abilify Maintena| 1 month | $3,000-$3,500 |
UZEDY's 2-month option often makes it cheaper per month ($1,500-$2,100) than monthly rivals.[1][5]
Where to check current pricing and patents?
Use tools like GoodRx for real-time pharmacy prices (often 10-20% below WAC with coupons) or Drugs.com for comparisons. UZEDY has no major patent disputes listed yet; core patents expire around 2036-2040 per DrugPatentWatch.[6][7]
[1]: GoodRx - UZEDY Pricing
[2]: Drugs.com - UZEDY Price Guide
[3]: Teva UZEDY Savings Program
[4]: Medicare Part D Lookup
[5]: RedBook/IBM Micromedex Pricing Data
[6]: DrugPatentWatch.com - UZEDY Patents
[7]: FDA Orange Book - UZEDY Approvals